Company to send 12 million doses of COVID-19 vaccine adapted to target Omicron.
Moderna is supplying Canada with 12 million COVID-19 shots specifically designed to target the Omicron variant of COVID-19.
Last year, the Canadian government entered into a supply deal with the company for supply of its COVID vaccine for 2022 and 2023.
The contract does allow for access to new adaptations of the vaccine.
Moderna and Canada have agreed to convert six million doses of the company's COVID vaccine, which targets the original virus, to an Omicron-containing bivalent one.
The country will also purchase an addition 4.5 million doses of the Omicron-targeted shot, and is moving forward with a scheduled delivery of 1.5 million shots of the bivalent vaccine.
While existing COVID-19 inoculations continue to provide protections against hospitalization and death, experts say the effectiveness of the vaccine has decreased as the virus has evolved.
Chief Public Health Officer Dr. Theresa Tam says Health Canada is still reviewing submissions for bivalent vaccines from Moderna and Pfizer.

Multiple Charges Laid after Thefts in Tillsonburg
CASS Offering Unique Program to Students
PJHL Preview - Jan. 30th to Feb. 1st
Woodstock Bowler Heading to Special Olympics
Dog Bite Investigation in Tillsonburg
Interview with the Warden - January 29th, 2026
Trevor Birtch Trial Daily Recap - Case 2
11 People Charged in Massive Drug Bust
Another Cold Warning for Oxford County
Chilly Charlie Returns on Monday
Khanna Shines a Light on Oxford County Superstars
WFD Responds to Structure Fire
WPS Appoints New Deputy Chief
TMMC Woodstock Begins Production of Sixth Gen RAV4
Oxford OPP Briefs - January 28th, 2026
More Weather Alerts for Oxford County
Thrive Oxford Honoured at ROMA
Tip Tuesday with the Oxford OPP - January 2026
Members Needed for Tillsonburg Housing Advisory Committee
UPDATE: Ottawa Approves Plan to Move Marineland's Whales and Dolphins
Comments
Add a comment